Subdiaphragmatic murine electrophysiological studies: Sequential determination of ventricular refractoriness and arrhythmia induction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 3 54-3, 2003, Pages

  Gutstein, David E ^a,b   Danik, Stephan B ^a   Sereysky, Jedd B ^a   Morley, Gregory E ^a   Fishman, Glenn I ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Artificial cardiac pacing; Electrophysiology; Heart; Mice

Indexed keywords

ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; HEART PACING; HEART VENTRICLE ARRHYTHMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0042860118     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00100.2003     Document Type: Article

References (21)

1. Baker LC, London B, Choi BR, Koren G, and Salama G. Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 86: 396-407, 2000.
2. Berul CI, Aronovitz MJ, Wang PJ, and Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation 94: 2641-2648, 1996.
3. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG, and Mendelsohn ME. Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice. J Clin Invest 99: 570-576, 1997.
4. Berul CI, Maguire CT, Aronovitz MJ, Greenwood J, Miller C, Gehrmann J, Housman D, Mendelsohn ME, and Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest 103: R1-7, 1999.
5. Berul CI, McConnell BK, Wakimoto H, Moskowitz IP, Maguire CT, Semsarian C, Vargas MM, Gehrmann J, Seidman CE, and Seidman JG. Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant Myosin-binding protein C gene. Circulation 104: 2734-2739, 2001.
6. Danik S, Cabo C, Chiello C, Kang S, Wit AL, and Coromilas J. Correlation of repolarization of ventricular monophasic action potential with ECG in the murine heart. Am J Physiol Heart Circ Physiol 283: H372-H381, 2002.
7. Exner DV, Klein GJ, and Prystowsky EN. Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: can we afford to do it? (Can we afford not to?). Circulation 104: 1564-1570, 2001.
8. Gallagher JD, Bianchi J, and Gessman LJ. A comparison of the electrophysiologic effects of acute and chronic amiodarone administration on canine Purkinje fibers. J Cardiovasc Pharmacol 13: 723-729, 1989.
9. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, and Fishman GI. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88: 333-339, 2001.
10. Huang J, Skinner JL, Rogers JM, Smith WM, Holman WL, and Ideker RE. The effects of acute and chronic amiodarone on activation patterns and defibrillation threshold during ventricular fibrillation in dogs. J Am Coll Cardiol 40: 375-383, 2002.
11. Huikuri HV, Castellanos A, and Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 345: 1473-1482, 2001.
12. Jeron A, Mitchell GF, Zhou J, Murata M, London B, Buckett P, Wiviott SD, and Koren G. Inducible polymorphic ventricular tachyarrhythmias in a transgenic mouse model with a long Q-T phenotype. Am J Physiol Heart Circ Physiol 278: H1891-H1898, 2000.
13. Knollmann BC, Katchman AN, and Franz MR. Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 12: 1286-1294, 2001.
14. Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyen-Tran VT, Gu Y, Ikeda Y, Chu PH, Ross J, Giles WR, and Chien KR. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 107: 801-813, 2001.
15. Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y, Smits JF, Flameng W, Clancy CE, Moons L, Vos MA, Dewerchin M, Benndorf K, Collen D, Carmeliet E, and Carmeliet P. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 7: 1021-1027, 2001.
16. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL Jr, Jouven X, Kuller LH, MacCluer JW, Marban E, Muller JE, Schwartz PJ, Siscovick DS, Tracy RP, Zareba W, and Zipes DP. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, part I. Circulation 103: 2361-2364, 2001.
17. Sun W, Sarma JS, and Singh BN. Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone. J Cardiovasc Pharmacol 39: 677-684, 2002.
18. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelsohn ME, and Saffitz JE. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation 97: 686-691, 1998.
19. Vaidya D, Morley GE, Samie FH, and Jalife J. Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis. Circ Res 85: 174-181, 1999.
20. + channel subunit in the mouse heart. Circ Res 85: 1067-1076, 1999.
21. Zheng ZJ, Croft JB, Giles WH, and Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104: 2158-2163, 2001.